Skip to main content

WELLS FARGO & COMPANY/MN

Position in ALXO — Alx Oncology Holdings Inc

CIK 72971 SAN FRANCISCO, CA

Position in ALXO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$206,846
+$206,661 QoQ
Shares Held
99,926
+22254.8% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 94 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALXO Over Time

Shares Held

Position Value (USD)

Derivatives in ALXO

reported options exposure · as of Dec 31, 2022
CallValue
$0
CallShares
0
PutValue
$11,270
PutShares
1,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. ALXO ranks #246 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ALXO

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $206,846 99,926
2025-06-30 $185 447
2025-03-31 $10,255 16,461
2024-12-31 $26,885 16,099
2024-09-30 $19,102 10,496
2024-06-30 $63,767 10,575
2024-03-31 $103,962 9,324
2023-12-31 $123,527 8,296
2023-09-30 $25,948 5,406
2023-06-30 $67,836 9,033
2023-03-31 $23,073 5,105
2022-12-31 $20,195 1,792
2022-12-31 $11,270 1,000
2022-09-30 $8,095 846
2022-06-30 $8,090 1,000
2022-06-30 $28,832 3,564
2022-03-31 $176,655 10,453
2021-12-31 $312,292 14,532
2021-09-30 $477,873 6,470
2021-06-30 $50,688 927
2021-03-31 $66,881 907
2020-12-31 $1,160,509 13,463
2020-09-30 $273,916 7,258